| Dr Walter Sussman, DO | |
|
20 Walnut St Ste 14, Wellesley, MA 02481-2104 | |
| (781) 591-7855 | |
| (781) 591-7854 |
| Full Name | Dr Walter Sussman |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 13 Years |
| Location | 20 Walnut St Ste 14, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538457684 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 073846 (Georgia) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 265681 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boston Sports And Biologics Pc | 6002225547 | 3 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
| Entity Name | Orthopedic Care Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679528046 PECOS PAC ID: 9537140207 Enrollment ID: O20040727000122 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
| Entity Name | New England Ambulatory Surgicenter, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1851491013 PECOS PAC ID: 0244238186 Enrollment ID: O20061201000163 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
| Entity Name | Orthopedic Care Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508121070 PECOS PAC ID: 7214185511 Enrollment ID: O20120911000656 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
| Entity Name | Boston Sports & Biologics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073194718 PECOS PAC ID: 6002225547 Enrollment ID: O20210512002704 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Walter Sussman, DO 35 United Dr Ste 102, West Bridgewater, MA 02379-1056 Ph: (508) 238-8646 | Dr Walter Sussman, DO 20 Walnut St Ste 14, Wellesley, MA 02481-2104 Ph: (781) 591-7855 |
News Archive
Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.
Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Technology has placed vast amounts of medical information literally a mouse click away. Yet what often may be central - a doctor's notes about a patient visit - has traditionally not been part of the discussion. In effect, such records have long been out of bounds.
› Verified 4 days ago
Mrs. Tracey Crossman, PA Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 378 Washington St, Wellesley, MA 02481 Phone: 781-489-5541 Fax: 781-489-5340 | |
Dr. Ariana Jessica Vora, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 65 Walnut St, Spaulding Newton Wellesley Rehab Center, Wellesley, MA 02481 Phone: 781-431-9144 Fax: 781-431-9152 | |
Dr. Erek W Latzka, MD, RMSK Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 20 Walnut St Ste 14, Wellesley, MA 02481 Phone: 781-591-7855 | |
Dr. Joanne Borg Stein, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 65 Walnut St, Spaulding Newton Wellesley Rehab Center, Wellesley, MA 02481 Phone: 781-431-9144 Fax: 781-431-9152 | |
Mr. David Andrew Norton, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 20 Walnut St Ste 14, Wellesley, MA 02481 Phone: 781-591-7855 | |
Dr. Elizabeth Pegg Frates, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 133 Lowell Rd, Wellesley, MA 02481 Phone: 781-431-9783 Fax: 781-431-9783 |